To identify new genetic modifiers for epidermolysis bullosa simplex (EBS), a team led by scientists at Tel Aviv Medical Center performed exome sequencing of 195 patients with EBS from 90 different ...
STATEN ISLAND, N.Y. — A fundraising Polar Plunge to honor John Hudson Dilgen will take place this month in South Beach to ...
New York Magazine on MSN5 天
How Do We Defend Science?
But if we’re going to defend public health, we have to identify its real enemies, and there’s a difference between a Texas ...
The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene ...
Sam Schulz, a 20-year-old with Epidermolysis Bullosa, has developed a close friendship with Ole Miss basketball coach Chris ...
The winner of the annual series between the Padres and Mariners will now win the Vedder Cup, a trophy designed by Pearl Jam ...
Jefferies analyst Roger Song initiated coverage of Krystal Biotech (KRYS) with a Buy rating and $245 price target Krystal is a commercial ...
The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials ...
Sam Schulz, a 20-year-old with Epidermolysis Bullosa, has developed a close friendship with Ole Miss basketball coach Chris Beard. Schulz, who is a big basketball fan, has become an inspiration to ...
Oppenheimer initiated coverage of Abeona Therapeutics (ABEO) with an Outperform rating and $16 price target The company’s main value driver is ...